Sirnagen Therapeutics Inc.
Clinical trials sponsored by Sirnagen Therapeutics Inc., explained in plain language.
Now part of
OliX Pharmaceuticals, Inc.
226950
KOSDAQ
A clinical-stage biopharmaceutical company developing RNAi-based therapies for rare diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.